CUSIP G8807B106COMTBPHQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
167 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Madison Avenue Partners, LP | 9.51M | $177.95M | 0 | Held |
| 2 | Weiss Asset Management LP | 7.46M | $139.52M | +7.46M | New |
| 3 | Newtyn Management, LLC | 4.30M | $80.45M | −650.0K | Reduced |
| 4 | Blackrock, Inc. | 4.05M | $75.79M |
| −18.5K |
| Reduced |
| 5 | Irenic Capital Management LP | 2.76M | $51.66M | 0 | Held |
| 6 | Vanguard Group Inc | 2.37M | $44.29M | +155.8K | Added |
| 7 | D. E. Shaw & Co., Inc. | 1.26M | $23.57M | +50.6K | Added |
| 8 | State Street Corp | 1.10M | $20.62M | +46.0K | Added |
| 9 | Arrowstreet Capital, Limited Partnership | 963.3K | $18.02M | +236.5K | Added |
| 10 | Geode Capital Management, LLC | 938.7K | $17.57M | +40.7K | Added |
See every fund holding Theravance Biopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders